LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Messenger RNA Quality Control Mechanism Explained

By Gerald M. Slutzky, PhD
Posted on 15 Nov 2016
Image: Schematic of a gateway in the nuclear membrane, known as the nuclear pore complex (NPC), and the proteins (shown as spheres) involved in transport and quality control of mRNAs (shown in red). A combination of a multitude of protein-protein interactions enables the cell to distinguish and keep aberrant mRNAs from exiting the nucleus (Photo courtesy of Mohammad Soheilypour, Berkeley National Laboratory).
Image: Schematic of a gateway in the nuclear membrane, known as the nuclear pore complex (NPC), and the proteins (shown as spheres) involved in transport and quality control of mRNAs (shown in red). A combination of a multitude of protein-protein interactions enables the cell to distinguish and keep aberrant mRNAs from exiting the nucleus (Photo courtesy of Mohammad Soheilypour, Berkeley National Laboratory).
Genomics researchers have described a mechanism that explains how molecules of messenger RNA (mRNA) are checked for accuracy before being released from the nucleus into the cytoplasm.

Export of mRNAs into the cytoplasm is a fundamental step in gene regulation processes, which undergo quality control by highly efficient mechanisms in eukaryotic cells. However, it remains unclear how the aberrant mRNAs are recognized and retained inside the nucleus.

To better understand the quality control process, investigators at Berkeley National Laboratory (CA, USA) and the University of California, Berkeley (USA) used a new modeling approach for complex systems, namely the agent-based modeling (ABM) approach, to develop a minimal model of the mRNA quality control (QC) mechanism.

They reported in the November 2, 2016, online edition of the journal Scientific Reports that regulation of the affinity of RNA-binding proteins (RBPs) to export receptors along with the weak interaction between the nuclear basket protein (Mlp1 or Tpr) and RBPs were the minimum requirements to distinguish and retain aberrant mRNAs. The results showed that the affinity between Tpr and RBPs was optimized to maximize the retention of aberrant mRNAs.

The length of the mRNA strand affected the QC process. Since longer mRNAs spent more time in the nuclear basket to form a compact conformation and initiate their export, nuclear basket proteins could more easily capture and retain them inside the nucleus.

"Just like all production lines, the process of genetic information transfer and protein production is quality controlled at different stages," said senior author Mohammad Mofrad, professor of bioengineering and of mechanical engineering at the University of California, Berkeley. "To date, the exact mechanism of this quality control step has remained unclear. Some components of this machinery are dysregulated in various types of cancers. Understanding the molecular mechanism of genetic information transport and quality control would substantially improve the current knowledge about various types of cancers and other human diseases."

Related Links:
Berkeley National Laboratory
University of California, Berkeley
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Rapid Molecular Testing Device
FlashDetect Flash10

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more